J&J says lung cancer drugs Rybrevant and Lazcluze extend survivaladminWe31WerJanuary 7, 20250 Niels Wenstedt | Getty ImagesJohnson & Johnson on Tuesday said its lung cancer regimen keeps people alive for at least…